SALOFALK FOAM mesalazine 1g/application aerosol can Australië - Engels - Department of Health (Therapeutic Goods Administration)

salofalk foam mesalazine 1g/application aerosol can

dr falk pharma australia pty ltd - mesalazine, quantity: 1 g - foam - excipient ingredients: propane; cetostearyl alcohol; disodium edetate; propylene glycol; butane; polysorbate 60; isobutane; sodium metabisulfite - salofalk foam enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.

SALOFALK ENEMAS mesalazine 2g/60mL enema bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

salofalk enemas mesalazine 2g/60ml enema bottle

dr falk pharma australia pty ltd - mesalazine, quantity: 2000 mg - enema - excipient ingredients: sodium benzoate; carbomer 934p; disodium edetate; potassium acetate; potassium metabisulfite; xanthan gum; purified water - salofalk enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.

SALOFALK ENEMAS mesalazine 4g/60mL enema bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

salofalk enemas mesalazine 4g/60ml enema bottle

dr falk pharma australia pty ltd - mesalazine, quantity: 4000 mg - enema - excipient ingredients: sodium benzoate; carbomer 934p; disodium edetate; potassium acetate; potassium metabisulfite; xanthan gum; purified water - salofalk enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.

SALOFALK ENEMAS mesalazine 2g/30mL enema bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

salofalk enemas mesalazine 2g/30ml enema bottle

dr falk pharma australia pty ltd - mesalazine, quantity: 2000 mg - enema - excipient ingredients: disodium edetate; potassium acetate; purified water; xanthan gum; potassium metabisulfite; carbomer 934p; sodium benzoate - salofalk enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.

Mesalazine I.P.S 250 mg gastro-resist. tabl. België - Engels - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

mesalazine i.p.s 250 mg gastro-resist. tabl.

international pharmaceutical services sa-nv - mesalazine 250 mg - gastro-resistant tablet - 250 mg - mesalazine 250 mg - mesalazine

Mesalazine I.P.S 500 mg gastro-resist. tabl. België - Engels - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

mesalazine i.p.s 500 mg gastro-resist. tabl.

international pharmaceutical services sa-nv - mesalazine 500 mg - gastro-resistant tablet - 500 mg - mesalazine 500 mg - mesalazine

Mesalazine Teva 500 mg gastro-resist. tabl. België - Engels - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

mesalazine teva 500 mg gastro-resist. tabl.

teva pharma belgium sa-nv - mesalazine 500 mg - gastro-resistant tablet - 500 mg - mesalazine 500 mg - mesalazine

PENTASA SLOW RELEASE TABLETS 1 GRAM Israël - Engels - Ministry of Health

pentasa slow release tablets 1 gram

ferring pharmaceuticals ltd - mesalazine - tablets slow release - mesalazine 1 g - mesalazine - mesalazine - mild to moderate ulcerative colitis. crohn's disease.

PENTASA SUPPOSITORIES Israël - Engels - Ministry of Health

pentasa suppositories

ferring pharmaceuticals ltd - mesalazine - suppositories - mesalazine 1000 mg - mesalazine - mesalazine - ulcerative proctitis.

PENTASA SLOW RELEASE TABLETS 500 MG Israël - Engels - Ministry of Health

pentasa slow release tablets 500 mg

ferring pharmaceuticals ltd - mesalazine - tablets slow release - mesalazine 500 mg - mesalazine - mesalazine - mild to moderate ulcerative colitis.crohn's disease